Skip to content Skip to left sidebar Skip to footer

COVID-19 Vaccine

COVID-19 Ancillary Kit Update

COVID-19 Ancillary Kit Update

All Moderna COVID-19 vaccine shipments will now include only one ancillary kit: one ancillary kit to one carton of vaccine, instead of two ancillary kits to one carton of vaccine. This change will take effect with orders placed beginning on Monday, April 11, 2022, at 10 am ET.

Providers are able to opt-out of future ancillary kit shipments (with the exception of Pfizer 5-11, as it requires diluent). In order to do so, please place a note in the comment section of your order if you are interested in opting out of Moderna, Janssen, and Gray Cap Pfizer supplies.

Although many providers are reporting an excess of ancillary supplies, PDPH is unable to accept any ancillary kits/supplies back from providers. Ancillary supplies can be donated domestically (not internationally) if sites are unable to use them. However, surplus CDC cards should be properly destroyed to avoid any misuse. If disposing of any needles, providers should utilize the appropriate sharps bins.

Email COVID@phila.gov with any questions.

HRSA Has Stopped Accepting COVID-19 Uninsured Claims

HRSA Has Stopped Accepting COVID-19 Uninsured Claims

CDC strongly encourages providers to continue administering vaccines.

Due to the lack of supplemental funding from Congress, HRSA has stopped accepting claims for reimbursement of costs associated with administering COVID-19 vaccines to uninsured and underinsured individuals as of 11:59 PM ET on April 5, 2022.  

CDC encourages providers to stay in the CDC COVID-19 Vaccination Program and continue administering these lifesaving vaccines at no cost to patients. CDC remains committed to ensuring equitable access to COVID-19 vaccines. 

As a reminder, COVID-19 Vaccination Program providers cannot:

  • Administer COVID-19 vaccine at any out-of-pocket cost to the recipient
  • Deny anyone vaccination, or differentially reducing appointment access, based on the vaccine recipient’s coverage status or network status
  • Charge an office visit or other fee if COVID-19 vaccination is the sole medical service provided
  • Require additional medical services to receive COVID-19 vaccination
  • Seek any reimbursement, including through balance billing, from the vaccine recipient

Where CDC becomes aware of a provider engaging in any of the following, CDC will consider taking any and all appropriate measures, including the possibility of rescinding the CDC provider agreement.

For further information, please see the CDC COVID-19 Vaccination Program Provider Requirements and Support webpage

Thank you for keeping Philadelphia safe and healthy. If you have any questions, please email vaccines@phila.gov.

New Resource Available for In-Home COVID Vaccination Providers

New Resource Available for In-Home COVID Vaccination Providers

There is a new resource available for COVID-19 providers who are vaccinating in the home. It contains contact and website information that can be used to report and assist with commonly encountered situations. Providers are welcome to utilize this information as needed and can also reach out to PDPH if they have any additional questions about in-home vaccinations.

Resources for In-Home Vaccine Providers

These resources can be used to report and assist with commonly encountered situations.

For legal assistance when encountering domestic violence, hoarding, home repair, or neighbor disputes, please contact:

For situations involving older adults, including elder abuse/crime, homecare and residential care, caregiver information and resources, or housing, home repair, food, legal resources, and transportation, please contact:

  • Center for Advocacy for the Rights and Interests of the Elderly (CARIE): www.carie.org | 1-800-356-3606
  • Philadelphia Corporation for Aging (PCA): www.pcacares.org | 215-765-9040

For other disability specific resources:

To report suspected instances of Child Abuse, call ChildLine at 1-800-932-0313.
To report suspected instances of Human Trafficking, call the National Human Trafficking Hotline at 1-888-373-7888.

For all urgent or life threatening emergencies, dial 9-1-1.

View printable resources.

FDA Authorizes Second COVID-19 Booster Dose

FDA Authorizes Second COVID-19 Booster Dose

On March 29, 2022, the U.S. Food and Drug Administration authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The FDA previously authorized a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This action will now make a second booster dose of these vaccines available to other populations at higher risk for severe disease, hospitalization, and death. Emerging evidence suggests that a second booster dose of an mRNA COVID-19 vaccine improves protection against severe COVID-19 and is not associated with new safety concerns.

The agency amended the emergency use authorizations as follows:

  • A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.
  • A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromise at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromise.
  • A second booster dose of the Moderna COVID-19 Vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID-19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromise.

The amendments to the EUAs to include a second booster dose for these populations were granted to Pfizer Inc. and ModernaTX Inc.

For the entire FDA press release, click here.

Emergency Use Authorizations:
Pfizer Vaccine: Pfizer-BioNTech COVID-19 Vaccine Information | CDC
Moderna: Moderna COVID-19 Vaccine Information | CDC
Janssen: Johnson & Johnson’s Janssen COVID-19 Vaccine Information | CDC

New Resources Available: Beyond-Use Date (BUD) Labels, Dose Trackers, and Storage Unit Guides

New Resources Available: Beyond-Use Date (BUD) Labels, Dose Trackers, and Storage Unit Guides

Vaccines must be maintained according to manufacturer guidelines to ensure vaccine viability. However, storing and administering multiple COVID-19 vaccine products can be confusing.

The following tools are intended to assist providers in storing, tracking BUD/expiration dates, and tracking vaccine administrations, as well as wastage. Please use the links below to access these resources.

Storage Unit Guides
BUD Labels
Dose Trackers

Janssen (J&J) Shelf-Life Extension

Johnson & Johnson’s Janssen Shelf-Life Extension


The Food & Drug Administration has approved a shelf-life extension for the Johnson & Johnson’s Janssen COVID-19 vaccine for an additional three months. The shelf-life of this vaccine has been updated from 6 months to 9 months. 

This decision is based on data from ongoing stability assessment studies, which have demonstrated that the vaccine is stable at 9 months when refrigerated at temperatures of 36° – 46° Fahrenheit (2° – 8° Celsius).

This shelf-life extension applies to all inventory dated to expire on March 7, 2022 or later. Vaccine dated prior to March 7, 2022 should be disposed of according to state and local regulation and reported as waste according to your COVID-19 provider agreement. 

Please refer to the current EUA fact sheet by clicking on the button below.


Vaccine providers should visit the Janssen COVID-19 Vaccine Expiry Checker webpage to confirm expiration dates. This shelf-life extension applies to refrigerated vials of J&J/Janssen COVID-19 vaccine that have been held in accordance with the manufacturer’s storage conditions.

Thank you for keeping Philadelphia safe and healthy. If you have any questions, please email vaccines@phila.gov.

Upcoming COVID-19 Vaccine Ordering Changes

Upcoming COVID-19 Vaccine Ordering Changes

Next week, COVID-19 vaccine orders will be due on Tuesday, February 22 at 5pm instead of Wednesday, February 23. Please submit your upcoming orders by Tuesday at 5pm instead of Wednesday in order for them to be processed.

For assistance with submitting your order, email:

Provider Education Coordinator
DPHProviderhelp@phila.gov

Vaccine Order Specialist
Christine Wilson
Christine.Wilson@phila.gov

Vaccine Order Specialist
Charma Miller
Charma.Miller@phila.gov

Pediatric COVID Vaccine Pre-Order Update

Pediatric COVID Vaccine Pre-Order Update

On Friday, February 11, the FDA released a statement about postponing the review of the Pfizer maroon cap product for ages 6 months to 4 years. The review meeting was originally scheduled for February 15. However, this meeting will now be taking place closer to April, as Pfizer has new data that they would like reviewed at that time. The FDA would also like to consider new data regarding the third dose in this age group.

Because of this postponement, Pfizer maroon cap will not be available for ordering at this time. Orders for maroon cap Pfizer will be removed from the queue at this time, until we have further guidance. We apologize for the confusion. Thank you all for being so responsive and getting orders submitted quickly.

As we receive additional information regarding the review and approval plans for this product, we will share them with providers. Please see the FDA press release for more information.

Younger Pediatric COVID-19 Vaccine Coming Soon!

Younger Pediatric COVID-19 Vaccine Coming Soon!

The COVID-19 vaccine for children 6 months through 4 years of age is expected to be approved as early as the end of February.

We need your help as trusted providers to ensure these children have access to vaccination.

Here’s why:

  • To ensure access. Children under 3 cannot be vaccinated in pharmacies and will have limited options of where to seek vaccination.
  • To meet a real need. Nationally, 70% of parents with kids in this age group are ready or close to ready to having their children vaccinated against COVID-19.
  • Parents trust you. The vast majority of these parents would prefer to take their children to their regular provider to be vaccinated.

Your practice is key to vaccinating these younger children.

Click below to watch a video statement from Philadelphia Health Commissioner, Cheryl Bettigole, on the importance of this initiative.

What Can Your Practice Do to Be Ready?

Enroll: If you have not already enrolled, enroll now in the COVID-19 vaccine distribution program.

Spread the word: Let your families know you will be offering COVID-19 vaccine as soon as it becomes available. Order COVID-19 outreach materials (stickers, buttons, posters) at no cost to your practice.

Order: Order vaccine early and often.

Thank you for keeping Philadelphia safe and healthy. If you have any questions, please email vaccines@phila.gov.

COVID-19 Vaccine Pre-Order for Children 6 Months through 4 Years of Age

COVID-19 Vaccine Pre-Order for Children 6 Months through 4 Years of Age

Preordering for the COVID-19 vaccine for children 6 months through 4 years of age is now open.

Please see below for the timetable for the COVID-19 vaccine roll-out for children between 6 months and 4 years of age (6mo-4yr). Everything shared below is contingent upon FDA & CDC approvals in the coming days and weeks.

Pre-Order Schedule:

  • Thursday, February 10, 11:00am ET: orders received by this time will be considered in the first order wave. Minimum order size for requests is 100 doses. Check Philavax Friday, February 11 to see the status of your order.
  • Monday, February 21: all providers that order in the first order wave must be able to receive the vaccine shipment on Monday, February 21, which is President’s Day, a state and federal holiday.

If you are not open on President’s Day, Monday, February 21, and would still like to pre-order the 6mo-4yr pediatric vaccine, place your order next week by Wednesday, February 16, 5:00pm ET. These orders will be delivered starting Tuesday, February 22 and continuing over the following days.

Regular vaccine ordering will tentatively begin on Friday, February 25, or approximately one week after the FDA approval and CDC recommendation. Providers will be responsible for managing second and potentially third doses (depending on the FDA authorization and CDC recommendation).

Shipment & Dosage Information

  • The vaccine for 6mo-4yr will come in a MAROON CAP vial.
  • The 6mo-4yr vaccine will come in packages of 100 doses (10 vials of 10 doses).
  • The 6mo-4yr vaccine will be 1/10 of the adult dose (3 mcg), packaged as a new product with a new NDC code.
  • The Pfizer vaccine formulations for ages 5–11 (Orange Cap) and for those ages 12+ (Purple & Gray Cap) CANNOT be used in place of the 6mo-4yr vaccine.
  • The vaccine can be stored in ULT freezers for 9 months and in the refrigerator for 10 weeks. It CANNOT be stored in a regular freezer.

Vaccine administration to this age group can only begin following a potential approval made by the CDC Director in conjunction with an ACIP recommendation.

If you have any questions, please email vaccines@phila.gov.